|
1
|
Benson AB, Venook AP, Al-Hawary MM, Azad
N, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D,
Garrido-Laguna I, et al: Rectal Cancer, Version 2.2022, NCCN
clinical practice guidelines in oncology. J Natl Compr Canc Netw.
20:1139–1167. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kim S, Huh JW, Lee WY, Yun SH, Kim HC, Cho
YB, Park Y and Shin JK: Predicting survival in locally advanced
rectal cancer with effective chemoradiotherapy response. Eur J Surg
Oncol. 50:1083612024. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guan B, Huang X, Xia H, Guan G and Xu B:
Prognostic value of mesorectal package area in patients with
locally advanced rectal cancer following neoadjuvant
chemoradiotherapy: A retrospective cohort study. Front Oncol.
12:9417862022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mirbagheri N, Kumar B, Deb S, Poh BR, Dark
JG, Leow CC and Teoh WM: Lymph node status as a prognostic
indicator after preoperative neoadjuvant chemoradiotherapy of
rectal cancer. Colorectal Dis. 16:O339–O346. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Maas M, Nelemans PJ, Valentini V, Das P,
Rödel C, Kuo LJ, Calvo FA, García-Aguilar J, Glynne-Jones R,
Haustermans K, et al: Long-term outcome in patients with a
pathological complete response after chemoradiation for rectal
cancer: A pooled analysis of individual patient data. Lancet Oncol.
11:835–844. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sethi G, Shanmugam MK, Ramachandran L,
Kumar AP and Tergaonkar V: Multifaceted link between cancer and
inflammation. Biosci Rep. 32:1–15. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Karki R, Man SM and Kanneganti TD:
Inflammasomes and cancer. Cancer Immunol Res. 5:94–99. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yamamoto A, Toiyama Y, Okugawa Y, Oki S,
Ide S, Saigusa S, Araki T and Kusunoki M: Clinical implications of
pretreatment: lymphocyte-to-monocyte ratio in patients with rectal
cancer receiving preoperative chemoradiotherapy. Dis Colon Rectum.
62:171–180. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ke TM, Lin LC, Huang CC, Chien YW, Ting WC
and Yang CC: High neutrophil-to-lymphocyte ratio and
platelet-to-lymphocyte ratio predict poor survival in rectal cancer
patients receiving neoadjuvant concurrent chemoradiotherapy.
Medicine (Baltimore). 99:e198772020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nagasaki T, Akiyoshi T, Fujimoto Y,
Fujimoto Y, Konishi T, Nagayama S, Fukunaga Y and Ueno M:
Prognostic impact of neutrophil-to-lymphocyte ratio in patients
with advanced low rectal cancer treated with preoperative
chemoradiotherapy. Dig Surg. 32:496–503. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dong M, Shi Y, Yang J, Zhou Q, Lian Y,
Wang D, Ma T, Zhang Y, Mi Y, Gu X and Fan R: Prognostic and
clinicopathological significance of systemic immune-inflammation
index in colorectal cancer: A meta-analysis. Ther Adv Med Oncol.
12:17588359209374252020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jian-Hui C, Iskandar EA, Cai ShI, Chen CQ,
Wu H, Xu JB and He YL: Significance of Onodera's prognostic
nutritional index in patients with colorectal cancer: A large
cohort study in a single Chinese institution. Tumor Biol.
37:3277–3283. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Okugawa Y, Toiyama Y, Oki S, Ide S,
Yamamoto A, Ichikawa T, Kitajima T, Fujikawa H, Yasuda H, Saigusa
S, et al: Feasibility of assessing prognostic nutrition index in
patients with rectal cancer who receive preoperative
chemoradiotherapy. JPEN J Parenter Enteral Nutr. 42:998–1007. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Eraslan E, Adas YG, Yildiz F, Gulesen AI,
Karacin C and Arslan UY: Systemic immune-inflammation index (SII)
predicts pathological complete response to neoadjuvant
chemoradiotherapy in locally advanced rectal cancer. J Coll
Physicians Surg Pak. 31:399–404. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Partl R, Paal K, Stranz B, Hassler E,
Magyar M, Brunner TB and Langsenlehner T: The Pre-Treatment
Platelet-to-Lymphocyte Ratio as a Prognostic Factor for
Loco-Regional Control in Locally Advanced Rectal Cancer.
Diagnostics (Basel). 13:6792023. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: the 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Camp RL, Dolled-Filhart M and Rimm DL:
X-tile: A new bio-informatics tool for biomarker assessment and
outcome-based cut-point optimization. Clin Cancer Res.
10:7252–7259. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim TG, Park W, Kim H, Choi DH, Park HC,
Kim SH, Cho YB, Yun SH, Kim HC, Lee WY, et al: Baseline
neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in rectal
cancer patients following neoadjuvant chemoradiotherapy. Tumori.
105:434–440. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zitvogel L, Pietrocola F and Kroemer G:
Nutrition, inflammation and cancer. Nat Immunol. 18:843–850. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Alwarawrah Y, Kiernan K and MacIver NJ:
Changes in nutritional status impact immune cell metabolism and
function. Front Immunol. 9:10552018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Buzby GP, Mullen JL, Matthews DC, Hobbs CL
and Rosato EF: Prognostic nutritional index in gastrointestinal
surgery. Am J Surg. 139:160–167. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun G, Li Y, Peng Y, Lu D, Zhang F, Cui X,
Zhang Q and Li Z: Impact of the preoperative prognostic nutritional
index on postoperative and survival outcomes in colorectal cancer
patients who underwent primary tumor resection: A systematic review
and meta-analysis. Int J Colorectal Dis. 34:681–689. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Y, Chen L, Zhang B, Song W, Zhou G,
Xie L and Yu D: Pretreatment inflammatory-nutritional biomarkers
predict responses to neoadjuvant chemoradiotherapy and survival in
locally advanced rectal cancer. Front Oncol. 11:6399092021.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Runau F, Collins A, Fenech GA, Ford E,
Dimitriou N, Chaudhri S and Yeung JM: A single institution's
long-term follow-up of patients with pathological complete response
in locally advanced rectal adenocarcinoma following neoadjuvant
chemoradiotherapy. Int J Colorectal Dis. 32:341–348. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hu B, Yang XR, Xu Y, Sun YF, Sun C, Guo W,
Zhang X, Wang WM, Qiu SJ, Zhou J and Fan J: Systemic
immune-inflammation index predicts prognosis of patients after
curative resection for hepatocellular carcinoma. Clin Cancer Res.
20:6212–6122. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen JH, Zhai ET, Yuan YJ, Wu KM, Xu JB,
Peng JJ, Chen CQ, He YL and Cai SR: Systemic immune-inflammation
index for predicting prognosis of colorectal cancer. World J
Gastroenterol. 23:6261–6272. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gold P and Freedman SO: Specific
carcinoembryonic antigens of the human digestive system. J Exp Med.
122:467–481. 1965. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Park IJ, Choi GS, Lim KH, Kang BM and Jun
SH: Serum carcinoembryonic antigen monitoring after curative
resection for colorectal cancer: Clinical significance of the
preoperative level. Ann Surg Oncol. 16:3087–3093. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lee JH, Kim DY, Kim SH, Cho HM, Shim BY,
Kim TH, Kim SY, Baek JY, Oh JH, Nam TK, et al: Carcinoembryonic
antigen has prognostic value for tumor downstaging and recurrence
in rectal cancer after preoperative chemoradiotherapy and curative
surgery: A multi-institutional and case-matched control study of
KROG 14–12. Radiother Oncol. 116:202–208. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Perez RO, são Julião GP, Habr-Gama A, Kiss
D, Proscurshim I, Campos FG, Gama-Rodrigues JJ and Cecconello I:
The role of carcinoembriogenic antigen in predicting response and
survival to neoadjuvant chemoradiotherapy for distal rectal cancer.
Dis Colon Rectum. 52:1137–1143. 2009. View Article : Google Scholar : PubMed/NCBI
|
